Investments in R&D provide Trademax with a penetrating growth of pharmaceutical and chemical products. Those products inherited with our core area of expertise have been marketed effectively in the United States, Europe, Asia, Latin America and Africa in their respective countries with specific needs of the development and scale-up of new process.

       We currently have over 45 dedicated product development engineers involved in our organic synthesis research and development programs for pharmaceutical and chemical industry. Of those are 3 doctors, 5 masters and 20 bachelors providing the feasible solution from kilo to commercial production with over 200 manufacturing staff. We have focused on the innovative research and development side, but we have actually approached more on the respect of customer’s anticipation and requirement. Therefore we are more commercialized to distribute our products with our production and partnership.

       Quality assurance through the systematically analytic process is the key to our success. In-process and final quality control are performed under the following devices:

       High Pressure Liquid Chromatograph LC-10AD
       LC-10AT
       Gas Chromatograph
       Ultra-Violet Spectrophotometer
       Chromatograph Data Working Station
       Auto-analytical Balance
       Visible Spectrophotometer

       Innovative research is a key feature of Trademax its technology business on high efficiency separation, synthesis and purification for many new products to increase our international competitiveness. This makes us a close collaboration and association with our customers in major pharmaceutical and chemical companies, and leading research institutes around the world subject to required specifications and objectives.

       Trademax Chemicals is committed to environments in its research and development. We actively apply the materials to our products with the improved technology in order to improve the quality of our environment. To pursue the protection of environment is our motivation and principle for developing new applications for our pharmaceuticals and chemical intermediates.